Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies

Immunocompromised individuals including patients with hematological malignancies constitute a population at high risk of developing severe disease upon SARS-CoV-2 infection. Protection afforded by vaccination is frequently low and the biology leading to altered vaccine efficacy is not fully understo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergamaschi, Cristina, Pagoni, Maria, Rosati, Margherita, Angel, Matthew, Tzannou, Ifigeneia, Vlachou, Margarita, Darmani, Ismini, Ullah, Amirah, Bear, Jenifer, Devasundaram, Santhi, Burns, Robert, Baltadakis, Ioannis, Gigantes, Stavros, Dimopoulos, Meletios-Athanasios, Pavlakis, George N., Terpos, Evangelos, Felber, Barbara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174567/
https://www.ncbi.nlm.nih.gov/pubmed/35693807
http://dx.doi.org/10.3389/fimmu.2022.899972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174567/
https://www.ncbi.nlm.nih.gov/pubmed/35693807
http://dx.doi.org/10.3389/fimmu.2022.899972

Ejemplares similares